Human Chorionic Gonadotropin (HCG) Market Analysis Showcases Growth Trends and Opportunity Forecast Until 2026
Human
chorionic gonadotropin hormone (HCG) is a hormone secreted by
the placenta after implantation of a fertilized zygote in the uterus.
The hormone also supports normal development of an egg and helps in
the stimulation of egg release from the ovary. The HCG is mainly used
to induce ovulation in the women under infertility treatment. It is
also used among males mostly to increase the sperm count and in young
boys, due to pituitary gland disorders and other diseases, due to
which the testicles of the young males does not drop down naturally
into the scrotum.
Download the PDF
brochure:
The HCG is usually
administered as an injection under the skin into a muscle. The HCG
can also be administered at home under the advice of a gynecologist
or a pharmacist. The HCG levels can be determined with the help of
urine or blood test. Result of specific test helps in the determining
accurate measurement of the levels. These tests are mostly used to
identify and confirm pregnancy or as a screening test to determine
birth defects.
According to Centers
of Disease Control and Prevention (CDC) in 2016, approximately 7.3
million women aged 15 - 44 have used infertility services. Moreover,
6.7% of the married women aged 15 - 44 were reported infertile.
According to Azura Vascular Care, around 17% of the couples in the
U.S. deal with infertility out of which 30% cases are a result of
male infertility. These numbers suggests significant demand for
infertility treatments, such as HCG in order for females to conceive
a child. According to a statistical survey conducted by HealthGrove,
pituitary gland disorders resulted into the death of around 205
people in 2015, out of which highest percentage belonged to white
men.
The global human
chorionic gonadotropin by Coherent Market Insights is segmented on
the basis of Technology, Therapeutic area, and end user.
On the basis
of technology, the global human chorionic gonadotropin is segmented
as:
-
Natural Source Extraction
-
Recombinant DNA Technology
On the basis
of therapeutic area, the global human chorionic gonadotropin market
is segmented as:
-
Female infertility treatment
-
Oligospermic Treatment
-
Cryptorchidism Treatment
-
Others
On the basis
of end user, the global human chorionic gonadotropin market is
segmented as:
-
Fertility Centers
-
Research Institutes
-
Others
Request for the
Customization Of the Business Report @
The key players
operating the global human chorionic gonadotropin market include
Merck & Co., Inc., EMD Sereno, Inc., Fresenius Kabi, Bristol
Myers Squibb Company, Ferring BV, and Kamia Biomedical Company.
Acris Antibodies developed a human chorionic gonadotropin hormone by
recombinant DNA technology that helps to prevent the disintegration
of the corpus luteum of the ovary thereby, maintaining levels of
progesterone production for healthy pregnancy in females.
North
America to dominate global human chorionic gonadotropin (HCG) market,
owing to rising frequency of infertility cases
On the basis of
geography, the global human chorionic gonadotropin market is
segmented into North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa. North America is the highest regional
contributor to the market and is expected to continue as a regional
dominator over the forecast years. This primarily owes to the rising
number of infertility cases as well as hormonal dysfunction among
young males and females as a result of changing lifestyle. According
to Mayo Clinic, around 25% of women fertility problems in the U.S.
are a result of ovulation issues that are mostly caused due to
dysfunction of human chorionic gonadotropin (HCG) hormone. Thus, the
rapidly increasing cases of infertility are expected to surge the
North America global human chorionic gonadotropin market.
About
Coherent Market Insights:
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Visit our
news Website: https://www.coherentwire.com
Comments
Post a Comment